02587 健康之路
HEALTHYWAY INC
HEALTHYWAY INC
| Register Close | 2024/12/23 IPO Closing Tomorrow |
| Listing Date | 2024/12/30 |
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
HealthyWay Inc. operate a digital health and medical service platform in China. The Group is the fourth largest digital health and medical service platform in terms of the number of registered individual users on its platform as of December 31, 2023, according to Frost & Sullivan. The Group is also the fifth largest digital health and medical service platform in terms of revenue in 2023 with market share below 5%.
--
The Group develops its services to enable key industry stakeholders in the digital health and wellness industry in China. These industry stakeholders primarily include individual users; corporations and institutions such as pharmaceutical companies, hospitals, insurance companies and local health authorities; and physicians.
--
For individual users, the Group mainly provides them with health and medical services through its platform, so that they are enabled to manage their health and wellness more easily. For corporations and institutions, the Group mainly provides corporate and digital marketing services to enhance their operational efficiency and support their business growth.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 500 |
GLOBAL OFFERING
| No. of Offer Shares | 25.00M shares |
| No. of International Offer Shares | 22.50M shares |
| No. of HK Offer Shares | 2.50M shares |
| Offer Price | $7.80 - $8.80 |
| Stock Code | 2587 |
| Sponsor(s) | CCB International Capital Limited |
| Underwriter(s) | CCB International Capital Limited, Shenwan Hongyuan Securities (H.K.) Limited, BOCI Asia Limited, Livermore Holdings Limited, Fosun International Securities Limited, Zhongtai International Securities Limited, China Everbright Securities (HK) Limited, Ruibang Securities Limited, Sinolink Securities (Hong Kong) Company Limited, Victory Securities Company Limited, Futu Securities International (Hong Kong) Limited, Patrons Securities Limited |
TIME TABLE
| Application Period | Dec 18 (Wed) - noon, Dec 23 (Mon) |
| Price Determination Date | Dec 24 (Tue) |
| Result Announcement Date | On or before Dec 27 (Fri) |
| Result Announcement Date | On or before Dec 27 (Fri) |
| Result Announcement Date | On or before Dec 30 (Mon) |
| Dealings in Shares commence on | Dec 30, 2024. (Mon) |
Reallocation of Shares Offered
| Times of HK Offer Shares Subscription | 15X - 50X | 50X - 100X | Over 100X |
| % of total shares reallocated to HK Offer | 30% | 40% | 50% |
Sales Statistics (HKD)
| Offer Price | $7.80 - $8.80 |
| Capitalization | 6.85B - 7.72B |
| NAV / share ($) | $0.21 - $0.23 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 8.3, the net proceeds raised would be HKD 121.20M, of which |
| 60.5% : For health and medical services and corporate and digital marketing services |
| 21% : Strategic investments or acquisitions |
| 14.5% : Research and development |
| 4% : Working capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).